# Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant

> **NCT06699797** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Envoy Medical Corporation** · enrollment: 56 (estimated)

## Conditions studied

- Sensori-Neural Deafness
- Sensorineural Hearing Loss
- Sensorineural Hearing Loss (Disorder)
- Sensorineural Hearing Loss, Bilateral
- Sensorineural Hearing Loss, Profound
- Sensorineural Hearing Loss, Severe

## Interventions

- **DEVICE:** Acclaim Cochlear Implant

## Key facts

- **NCT ID:** NCT06699797
- **Lead sponsor:** Envoy Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-02-06
- **Primary completion:** 2027-04
- **Final completion:** 2028-04
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06699797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06699797, "Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06699797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*